Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...
Background/aim Clinical uncertainty remains regarding optimal atropine concentration, treatment duration and potential differences in efficacy for myopia control between Asian and non-Asian children.
Aims The impact of genetic variants on high myopia (HM) remains unclear. This study aims to systematically evaluate the relationship between genetic polymorphisms and HM. Methods Eligible studies were ...
Aims Differentiating pterygium from ocular surface squamous neoplasia (OSSN) is important for guiding management. This meta-analysis evaluates the prevalence and risk factors for incidental OSSN in ...
Dana Center for Preventive Ophthalmology, Wilmer Eye Institute, Johns Hopkins University, Baltimore, Maryland, USA Correspondence to Dr S West, Wilmer Eye Institute, Room 129, Johns Hopkins Hospital, ...
Background/aims During the last decade, improved neonatal care has resulted in increased survival of the most immature infants and improved health of more mature infants. We hypothesise that this has ...
Correspondence to Nilpa Shah, NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK; ...
Department of Ophthalmology and Visual Science, Tokyo Medical and Dental University, Tokyo, Japan Correspondence to: Kyoko Ohno-Matsui, MD, Department of Ophthalmology and Visual Science, Tokyo ...
Global burdens and causes of blindness and vision loss in children and adolescents from 1990 to 2021 and forecast for the next decade ...
AIM To confirm the accuracy of the Pulsair 3000 before introducing the instrument into clinical practice. METHOD A masked study by two experienced tonometrists comparing the mean of the Goldmann ...
Methods This was a population-based study of 3098 non-Indigenous Australians (50–98 years) and 1738 Indigenous Australians (40–92 years) stratified by remoteness. Each participant underwent a standard ...
Aims Topical ciclosporin A (CsA) is a therapeutic option for dry eye disease (DED) to control ocular surface inflammation and improve tear function. The aim of this study is to systematically review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results